Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review

Abstract

Background: Several natural products have been reported to elicit beneficial effects against neurodegenerative disorders due to their vitamin E contents. However, the neuroprotective efficacy of palm oil or its tocotrienol-rich fraction (TRF) from the pre-clinical cell and animal studies have not been systematically reviewed. Methods: The protocol for this systematic review was registered in “PROSPERO” (CRD42019150408). This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The Medical Subject Heading (MeSH) descriptors of PubMed with Boolean operators were used to construct keywords, including (“Palm Oil”[Mesh]) AND “Nervous System”[Mesh], (“Palm Oil”[Mesh]) AND “Neurodegenerative Diseases”[Mesh], (“Palm Oil”[Mesh]) AND “Brain”[Mesh], and (“Palm Oil”[Mesh]) AND “Cognition”[Mesh], to retrieve the pertinent records from PubMed, Scopus, Web of Science and ScienceDirect from 1990 to 2019, while bibliographies, ProQuest and Google Scholar were searched to ensure a comprehensive identification of relevant articles. Two independent investigators were involved at every stage of the systematic review, while discrepancies were resolved through discussion with a third investigator. Results: All of the 18 included studies in this review (10 animal and eight cell studies) showed that palm oil and TRF enhanced the cognitive performance of healthy animals. In diabetes-induced rats, TRF and α-tocotrienol enhanced cognitive function and exerted antioxidant, anti-apoptotic and anti-inflammatory activities, while in a transgenic Alzheimer’s disease (AD) animal model, TRF enhanced the cognitive function and reduced the deposition of β-amyloid by altering the expression of several genes related to AD and neuroprotection. In cell studies, simultaneous treatment with α-tocotrienols and neurotoxins improved the redox status in neuronal cells better than γ- and δ-tocotrienols. Both pre-treatment and post-treatment with α-tocotrienol relative to oxidative insults were able to enhance the survival of neuronal cells via increased antioxidant responses. Conclusions: Palm oil and its TRF enhanced the cognitive functions of healthy animals, while TRF and α-tocotrienol enhanced the cognitive performance with attenuation of oxidative stress, neuroinflammation and apoptosis in diabetes-induced or transgenic AD animal models. In cell studies, TRF and α-tocotrienol exerted prophylactic neuroprotective effects, while α-tocotrienol exerted therapeutic neuroprotective effects that were superior to those of γ- and δ-tocotrienol isomers.

Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis

“…Palm oil-derived tocotrienol-rich fraction (TRF) has been reported to provide immense protection against cytotoxicity caused by oxidative stress (OS) in rat striatal cells [ 19 ]. A recent systematic review on the safety and neuroprotective efficacy of palm-oil and TRF concluded that T3 could enhance the healthy animals’ cognitive function and attenuate OS [ 20 ]. According to Khanna et al, α-T3 exhibits cellular protection of the nerves through two main pathways: 12-lipoxygenase (LOX) and c-Src pathways [ 21 ].…”

Palm Oil Processing and Controversies over Its Health Effect: Overview of Positive and Negative Consequences

“…Palm oil is the world s most commonly used vegetable oils, and present in around half of frequently used food and consumer products, from snacks to cosmetics 4) . In 2020/2021, 75 million metric tons palm oil is produced globally; Indonesia and Malaysia are the leading producers and followed by Thailand and Colombia.…”

Efficacy of Edible Bird’s Nest on Cognitive Functions in Experimental Animal Models: A Systematic Review

“…Then the risk of bias was assessed within each included study and across the whole studies. After that, any study showed more than four domains of high risks, it was excluded [ 34 ]. The appraisal of the risks of bias was implemented by two independent investigators (A.A. and M.A.A.…”